Activation of particulate guanylyl cyclase by Vibrio vulnificus hemolysin

European Journal of Pharmacology

Volumn 365, Issue 2-3, 1999, Pages 267-272

  Kook, Hyun ^a   Rhee, Joon Haeng ^a   Lee, Shee Eun ^a   Kang, Seon Young ^a   Chung, Sun Sik ^a   Cho, Kyung Woo ^b   Baik, Yung Hong ^a  

^a Chonnam National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Guanylyl cyclase; Hemolysin; Rat; Vasodilatation; Vibrio vulnificus

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 6 ANILINO 5,8 QUINOLINEQUINONE; EXOTOXIN; GUANYLATE CYCLASE; HEMOLYSIN; HS 142 1;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMOLYSIS; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION; VIBRIO VULNIFICUS;

ADENOSINE TRIPHOSPHATE; ADENYLYL IMIDODIPHOSPHATE; AMINOQUINOLINES; ANIMALS; AORTA, THORACIC; CELL MEMBRANE; CHOLESTEROL; CYTOSOL; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; GUANYLATE CYCLASE; HEMOLYSIN PROTEINS; MALE; MUSCLE, SMOOTH, VASCULAR; OXADIAZOLES; POLYSACCHARIDES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; VIBRIO;

EID: 0032961885     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00870-X     Document Type: Article

References (27)

1. Bhakdi S., Grimminger F., Suttorp N., Walmrath D., Seeger W. Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Med. Microbiol. Immunol. 183:1994;119-144.
2. Bhakdi S., Bayley H., Valeva A., Walev I., Walker B., Weller U., Kehoe M., Palmer M. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch. Microbiol. 165:1996;73-79.
3. Blake P.A., Merson M.H., Weaver R.E., Hollis D.G., Heublein P.C. Disease caused by a marine Vibrio. N. Engl. J. Med. 300:1979;1-6.
4. Chinkers M., Garbers D.L. The protein kinase domain of the ANP receptor is required for signaling. Science. 245:1989;1392-1394.
5. Fussle R., Bhakdi S., Sziegoleit A., Granum-Jensen J., Kranz T., Wellensiek H.J. On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J. Cell. Biol. 91:1981;83-94.
6. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
7. Gray L.D., Kreger A.S. Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus. Infect. Immun. 48:1985;62-72.
8. Grimminger F., Rose F., Sibelius U., Meinhardt M., Potzsch B., Spriestersbach R., Bhakdi S., Suttorp N., Seeger W. Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. J. Immunol. 159:1997;1909-1916.
9. Ijioma S.C., Challiss R.A., Boyle J.P. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle. Br. J. Pharmacol. 115:1995;723-732.
10. Kim H.R., Rho H.W., Jeong M.H., Park J.W., Kim J.S., Park B.H., Kim U.H., Park S.D. Hemolytic mechanism of cytolysin produced from Vibrio vulnificus. Life Sci. 53:1993;571-577.
11. Kook H., Lee S.E., Baik Y.H., Chung S.S., Rhee J.H. Vibrio vulnificus hemolysin dilates rat thoracic aorta by activating guanylate cyclase. Life Sci. 59:1996;PL41-PL47.
12. Kothary M.H., Kreger A.S. Purification and characterization of an elastolytic protease of Vibrio vulnificus. J. Gen. Microbiol. 133:1987;1783-1791.
13. Kreger A., Lockwood D. Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect. Immun. 33:1981;583-590.
14. Kurose H., Inagami T., Ui M. Participation of adenosine 5′-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Lett. 219:1987;375-379.
15. Lad S. Activation of rat lung particulate guanylate cyclase by cholesterol-sequestering agents. Biochem. Biophys. Res. Commun. 97:1980;1199-1205.
16. Moncada S., Higgs E.A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
17. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
18. Morishita Y., Takahashi M., Sano T., Kawamoto I., Ando K., Sano M., Saitoh Y., Kase H., Matsuda Y. Isolation and purification of HS-142-1, a novel nonpeptide antagonist for the atrial natriuretic peptide receptor, from Aureobasidium sp. Agric. Biol. Chem. 55:1991;3017-3025.
19. - cotransport in vascular smooth muscle cells. J. Biol. Chem. 261:1986;15461-15466.
20. Park S.D., Shon H.S., Joh N.J. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J. Am. Acad. Dermatol. 24:1991;397-403.
21. Rapoport R.M., Murad F. Effects of ethacrynic acid and cystamine on sodium nitroprusside-induced relaxation, cyclic GMP levels and guanylate cyclase activity in rat aorta. Gen. Pharmacol. 19:1988;61-65.
22. Schulkes C.C.G.M., Schoen C.D., Arents J.C., Van Driel R. A soluble factor and GTPγS are required for Dictyostelium discoideum guanylate cyclase activity. Biochim. Biophys. Acta. 1135:1992;73-78.
23. Seeger W., Bauer M., Bhakdi S. Staphylococcal α-toxin elicits hypertension in isolated rabbit lungs: evidence for thromboxane formation and the role of extracellular calcium. J. Clin. Invest. 74:1984;849-858.
24. Shigematsu Y., Vaughn J., Frohlich E.D., Cole F.E. Adenosine 5′-triphosphate, phorbol ester, and pertussis toxin effects on atrial natriuretic peptide stimulation of guanylate cyclase in a human renal cell line. Life Sci. 54:1994;213-221.
25. Sobey C.G., Faraci F.M. Effects of novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke. 28:1997;837-843.
26. Steiner A.L., Parker C.W., Kipnis D.M. Radioimmunoassay for cyclic nucleotides: I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem. 247:1972;1106-1113.
27. Winquist R.J., Faison E.P., Waldman S.A., Schwartz K., Murad F., Rapoport R.M. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc. Natl. Acad. Sci. USA. 81:1984;7661-7664.